Vineet Laboratories Limited (NSE:VINEETLAB)

Market Cap	291.51M
Revenue (ttm)	769.82M
Net Income (ttm)	-201.91M
Shares Out	9.22M
EPS (ttm)	-21.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	809
Average Volume	23,838
Open	31.65
Previous Close	32.27
Day's Range	31.62 - 31.65
52-Week Range	26.51 - 78.45
Beta	-0.30
RSI	51.57
Earnings Date	May 28, 2025

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and fine chemicals in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid,...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 79
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VINEETLAB